HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness

HIV-1 matrix protein p17 and its variants promote human triple negative breast cancer cell aggressiveness

Abstract Background The introduction of cART has changed the morbidity and mortality patterns affecting HIV-infected (HIV+) individuals. The risk of breast cancer in HIV+ patients has now approached the general population risk. However, breast cancer has a more aggressive clinical course and poorer...

Full description

Bibliographic Details
Main Authors: Francesca Caccuri, Francesca Giordano, Ines Barone, Pietro Mazzuca, Cinzia Giagulli, Sebastiano Andò, Arnaldo Caruso, Stefania Marsico
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Infectious Agents and Cancer
Subjects:
HIV-1 matrix protein p17
p17 variants
Breast cancer
Motility
Clonogenicity
ERK1/2 signaling pathway
Online Access:http://link.springer.com/article/10.1186/s13027-017-0160-7

Internet

http://link.springer.com/article/10.1186/s13027-017-0160-7

Similar Items